1372. Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease.
作者: William B Feldman.;Aaron S Kesselheim.;Jerry Avorn.;Massimiliano Russo.;Shirley V Wang.
来源: Ann Intern Med. 2024年177卷1期eL230429页 1374. Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease : A Population-Based Cohort Study.
作者: Alvi A Rahman.;Sophie Dell'Aniello.;Erica E M Moodie.;Madeleine Durand.;Janie Coulombe.;Jean-François Boivin.;Samy Suissa.;Pierre Ernst.;Christel Renoux.
来源: Ann Intern Med. 2024年177卷2期144-154页
North American and European health agencies recently warned of severe breathing problems associated with gabapentinoids, including in patients with chronic obstructive pulmonary disease (COPD), although supporting evidence is limited.
1375. Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis : A Randomized Clinical Trial.
作者: Rajnish Mehrotra.;Daniel Cukor.;Susan M McCurry.;Tessa Rue.;Maria-Eleni Roumelioti.;Patrick J Heagerty.;Mark Unruh.
来源: Ann Intern Med. 2024年177卷2期177-188页
Chronic insomnia is common in patients undergoing in-center hemodialysis, yet there is limited evidence on effective treatments for this population.
1378. Osteoporosis.
Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. Evidence-based screening strategies improve identification of patients who are most likely to benefit from drug treatment to prevent fracture. In addition, careful consideration of when pharmacotherapy should be started, choice of medication, and duration of treatment maximizes the benefits of fracture prevention while minimizing potential harms of long-term drug exposure.
1380. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
作者: Ousseny Zerbo.;Joan Bartlett.;Bruce Fireman.;Ned Lewis.;Kristin Goddard.;Kathleen Dooling.;Jonathan Duffy.;Jason Glanz.;Allison Naleway.;James G Donahue.;Nicola P Klein.
来源: Ann Intern Med. 2024年177卷2期189-195页
A 2-dose series of recombinant zoster vaccine (RZV) was 97% effective against herpes zoster (HZ) in a pivotal clinical trial.
|